KO vs LXRX · P/E 25, rev $47.94B vs rev $21.8M
The Coca-Cola Company (KO) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
KO currently screens at market cap $343.90B and trailing P/E 25.1. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the KO and LXRX stock pages for the full models.
Not investment advice.